Publications

C-Path and experienced private sector partners collaborated with global health organizations to create didactic video materials...

Digital measures may provide objective, sensitive, real-world measures of disease progression in Parkinson’s disease (PD).

Artificial Intelligence (AI) and Digital Health Technologies (DHTs) are radically transforming drug development. The FDA and EMA..

Recent breakthroughs in natural language processing (NLP), particularly in large language models (LLMs), offer substantial...

Neurological disorders represent some of the most challenging therapeutic areas for successful drug approvals.

To address the challenges of assessing the impact of a reasonably likely surrogate endpoint on long-term graft survival....